Oxygenta (OXYGENTAPH) | Stock Overview & Key Data
Oxygenta Performance Comparison
Stock Range
Today's Range
Low: ₹80.00
High: ₹82.95
on August 22, 2025
52 Week Range
Low: ₹35.80
High: ₹133.50
on August 22, 2024
on June 9, 2025
All-Time High: ₹133.50 on June 9, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR3.0B
EPS
-2.86
P/E Ratio (TTM)
444.32
Forward P/E
N/A
P/B Ratio
N/A
PEG Ratio
N/A
Div. Yield
N/A
ROE
40.16%
Beta
0.556
Debt to Equity
-2.43
Financial Highlights
Profitability
Gross Margin
4.52%
Operating Margin
-50.72%
Profit Margin
-13.45%
Returns and Earnings
Return on Assets (TTM)
-12.44%
Return on Equity (TTM)
40.16%
EBITDA
INR-131.2M
Net Income (TTM)
INR-150.4M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR30.23
Quarterly Revenue Growth (YoY)
19.90%
Quarterly Earnings Growth (YoY)
368.77%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Oxygenta OXYGENTAPH | 3.01B Small-cap | -9.18% | -27.15% | -10.28% | -0.25% | -5.93% | 99.93% | 193.27% | 211.39% |
| Sun Pharmaceutical SUNPHARMA | 3.92T Large-cap | 0.07% | -2.94% | -5.16% | -0.08% | -13.09% | -7.63% | 86.35% | 195.13% |
| Divi's Laboratories DIVISLAB | 1.64T Large-cap | -1.70% | -9.87% | -8.00% | 4.71% | -0.74% | 24.14% | 68.03% | 84.18% |
| Sun Pharma Advanced SPARC | 47.77B Small-cap | 3.43% | -9.83% | -12.50% | 12.07% | -27.72% | -34.90% | -37.57% | -23.72% |
| Aarti Drugs AARTIDRUGS | 44.80B Small-cap | -3.22% | -13.59% | -0.59% | 21.36% | 3.40% | -16.47% | 7.52% | -35.72% |
| Sequent Scientific SEQUENT | 44.30B Small-cap | -0.44% | -6.77% | -2.09% | 9.71% | -5.23% | 5.57% | 52.75% | 30.80% |
Ownership & Short Interest
Insider Ownership
78.88%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
8K
Average 90-Day Volume
5K
Oxygenta Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Oxygenta would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is OXYGENTAPH's 52-week high and low?
- In the last 52 weeks, Oxygenta reached a high of ₹133.50 (on June 9, 2025) and a low of ₹35.80 (on August 22, 2024).
- What is the market cap and P/E ratio for OXYGENTAPH?
- Curious about Oxygenta's size and valuation? Its market capitalization stands at 3.01B. When it comes to valuation, the P/E ratio (trailing twelve months) is 444.32, and the forward P/E (looking ahead) is N/A.
- Does OXYGENTAPH pay dividends? If so, what's the yield?
- As for dividends, Oxygenta isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Oxygenta's main competitors or similar companies to consider before investing?
When looking at Oxygenta, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.92T Healthcare Drug Manufacturers - Specialty & Generic -7.63% 86.35% Divi's Laboratories
DIVISLAB1.64T Healthcare Drug Manufacturers - Specialty & Generic 24.14% 68.03% Sun Pharma Advanced
SPARC47.77B Healthcare Drug Manufacturers - Specialty & Generic -34.90% -37.57% Aarti Drugs
AARTIDRUGS44.80B Healthcare Drug Manufacturers - Specialty & Generic -16.47% 7.52% Sequent Scientific
SEQUENT44.30B Healthcare Drug Manufacturers - Specialty & Generic 5.57% 52.75% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Oxygenta Pharmaceutical Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Oxygenta's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 40.16%, the Debt to Equity ratio from the most recent quarter is -2.43, and its Gross Profit Margin stands at 4.52%.
- What is the recent revenue and earnings growth for OXYGENTAPH?
- Looking at Oxygenta's growth, its revenue over the trailing twelve months (TTM) was INR1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 19.90%, and quarterly earnings saw a YoY growth of 368.77%.
- How much of OXYGENTAPH stock is held by insiders and institutions?
- Wondering who owns Oxygenta stock? Company insiders (like executives and directors) hold about 78.88% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.